Historique
Heroin Addiction and Related Clinical Problems, Vol.17, n°1. - March 2015
| Titre : | Heroin Addiction and Related Clinical Problems, Vol.17, n°1. - March 2015 |
| Type de document : | Bulletin |
| Paru le : | 01/03/2015 |
Dépouillements
Ajouter le résultat à votre sélection
V. NIKOLAOU ;
J. LUTY
|
2015
Dans Heroin Addiction and Related Clinical Problems (Vol.17, n°1, March 2015) Article : Périodique
Dans Heroin Addiction and Related Clinical Problems (Vol.17, n°1, March 2015) Article : Périodique
Aim: Identify factors which may be responsible for variations in methadone-related deaths in Scotland.
Method: Computer modelling based on data from drug-related deaths in Scotland in 2012 was used to predict the most effective combination of [...]
M. GOUVEIA ;
R. SOUSA ;
J. COSTA ;
M. BORGES
|
2015
Dans Heroin Addiction and Related Clinical Problems (Vol.17, n°1, March 2015) Article : Périodique
Dans Heroin Addiction and Related Clinical Problems (Vol.17, n°1, March 2015) Article : Périodique
Background: According to a recent Portuguese study the prevalence of lifetime consumption of heroin in the global population (age range: 15-74 years) is 0.5%. Methadone is the standard pharmacological treatment, while buprenorphine has been avai[...]
S. BAGGIO ;
K. IGLESIAS ;
N. FOURNIER ;
J. STUDER ;
A. N'GORAN ;
S. DELINE ;
M. MOHLER-KUO ;
G. GMEL
|
2015
Dans Heroin Addiction and Related Clinical Problems (Vol.17, n°1, March 2015) Article : Périodique
Dans Heroin Addiction and Related Clinical Problems (Vol.17, n°1, March 2015) Article : Périodique
Background. So far few studies have focused on the last steps of drug-use trajectories. Heroin has been described as a final stage, but the non-medical use of prescription opioids (NMUPOs) is often associated with heroin use. There is, however, [...]